For the quarter ending 2025-09-30, VANI made $6,920K in revenue. -$6,530K in net income. Net profit margin of -94.36%.
| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development, net of grants | 4,519 | 4,759 | ||
| General and administrative, net of grants | 2,206 | 2,703 | ||
| Total operating expenses | 6,725 | 7,462 | ||
| Loss from operations | -6,725 | -7,462 | ||
| Other income, net | 195 | 318 | ||
| Net loss | -6,530 | -7,144 | ||
| Net loss per common share - basic (in dollars per share) | -0.11 | -0.12 | ||
| Net loss per common share - diluted (in dollars per share) | -0.11 | -0.12 | ||
| Weighted average common shares outstanding - basic (in shares) | 59,711,000 | 59,244,000 | ||
| Weighted average common shares outstanding - diluted (in shares) | 59,711,000 | 59,244,000 | ||
Vivani Medical, Inc. (VANI)
Vivani Medical, Inc. (VANI)